Genitourinary syndrome of menopause: optimization of therapyfor vaginal symptoms

Cover Page

Cite item

Full Text

Abstract

The aim of the study was to investigate the dynamics of atrophic changes оn the use of low-dose regimens of local therapy with a druge containing only estriol and a druge containing estriol, progesterone and a culture of lactobacilli in patients with postmenopausal vulvovaginal atrophy on the basis of subjective and objective criteria. Materials and methods. 44 patients with vulvovaginal atrophy were randomized into 2 groups of 22 people. In the first group, a drug containing estriol in a dose of 0.5 mg was used, in the second group, a preparation containing a lyophilized culture of lactobacilli, estriol - 0.2 mg; progesterone - 2.0 mg was used. Methods of the study included questioning of patients, cytological examination of the vaginal wall with evaluation of the epithelial maturation index, pH-metrics of the vaginal secretion, definition of the vaginal health index (IVS), PCR diagnostics of the vaginal biocenosis. Results. The use of a low-dose regimen of local therapy with estriol contributed to the restoration of the vaginal epithelium, which was confirmed by a statistically significant increase in ISEV and IVS, in the number of lactobacilli and a decrease in pH, However, the use of a combination drug led to a more effective recovery of lactoflora and normalization of the vaginal microflora.

About the authors

E G Eprikyan

V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation

Email: eldo989@rambler.ru
аспирант отд-ния гинекологической эндокринологии 117997, Russian Federation, Moscow, ul. Akademika Oparina, d. 4

S V Yureneva

V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation

Email: syureneva@gmail.ru
д-р мед. наук, вед. науч. сотр. отд-ния гинекологической эндокринологии 117997, Russian Federation, Moscow, ul. Akademika Oparina, d. 4

E I Ermakova

V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation

Email: ermakova.health@mail.ru
секретарь Российской ассоциации по менопаузе 117997, Russian Federation, Moscow, ul. Akademika Oparina, d. 4

A V Glazunova

V.I.Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation

Email: lianochka185@yandex.ru
аспирант отд-ния гинекологической эндокринологии 117997, Russian Federation, Moscow, ul. Akademika Oparina, d. 4

References

  1. Portman D.J, Gass M.L. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and The North American Menopause Society. Menopause 2014; 21: 1063-8.
  2. Сметник В.П., Юренева С.В., Ермакова Е.И., Глазунова А.В. Генитоуринарный менопаузальный синдром. Клинические рекомендации (проект). Менопауза. 2015; 1: 18.
  3. The 2017 hormone therapy position statement of The North American Menopause Society NAMS. Menopause: J North Am Menopause Soc 2017; 24 (7).
  4. Frank S.M, Ziegler C, Kokot-Kierepa M et al. Vaginal Health: Insights, Views & Attitudes (VIVA) survey - Canadian cohort. Menopause Int 2012.
  5. Caruso S, Cianci S. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel. Menopause 2016; 23 (1).
  6. Hummelen R, Macklaim J.M. Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness. PLoS One 2011; 6 (11).
  7. Jaisamrarn U, Triratanachat S, Chaikittisilpa et al. Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy. Climacteric 2013; 16: 347-55.
  8. Pickar J.H. Emerging therapies for postmenopausal vaginal atrophy. Maturitas 2013; 75: 3-6.
  9. Position Statement Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society. J Menopause 2013; 20 (9): 888-902.
  10. Rahn D.D, Ward R.M, Sanses T.V et al. Society of Gynecologic Surgeons Systematic Review Group. Vaginal estrogen use in postmenopausal women with pelvic floor disorders: systematic review and practice guidelines. Int Urogynecol J 2015; 26: 3-13.
  11. Sinha A, Ewies A.A. Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview. Climacteric 2013; 16: 305-12.
  12. Глазунова А.В. Клинико-патогенетическое обоснование ведения женщин с вагинальной атрофией в постменопаузе с учетом особенностей микробиоценоза влагалища и отдельных звеньев локального иммунитета. Автореф. дис. … канд. мед. наук. М., 2017

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).